RXRX - Recursion Pharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

RXRX is currently covered by 7 analysts with an average price target of $12.85. This is a potential upside of $4.91 (61.84%) from yesterday's end of day stock price of $7.94.

Recursion Pharmaceuticals's activity chart (see below) currently has 11 price targets and 37 ratings on display. The stock rating distribution of RXRX is 36% HOLD and 64% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 64.29% with an average time for these price targets to be met of 48.43 days.

Highest price target for RXRX is $33, Lowest price target is $10, average price target is $12.85.

Most recent stock forecast was given by SCOTT SCHOENHAUS from KEYBANK on 04-Mar-2024. First documented stock forecast 11-May-2021.

Best performing analysts who are covering RXRX - Recursion Pharmaceuticals:

Gil Blum Eric Joseph Michael Ryskin Scott Schoenhaus Salveen Richter Mani Foroohar Gal Munda

Currently out of the existing stock ratings of RXRX, 9 are a HOLD (36%), 16 are a BUY (64%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

16

$8.06 (101.51%)

15

1 months 21 days ago

2/4 (50%)

$3.7 (30.08%)

35

Buy

17

$9.06 (114.11%)

15

1 months 28 days ago

2/10 (20%)

$4.06 (31.38%)

71

Hold

10

$2.06 (25.94%)

32

5 months 12 days ago

2/2 (100%)

$4.17 (71.53%)

35

Buy

33

$25.06 (315.62%)

38

9 months 13 days ago

0/3 (0%)

$20.92 (173.18%)

Hold

8

$0.06 (0.76%)

9

1 years 3 months 2 days ago

4/5 (80%)

$-0.71 (-8.15%)

63

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RXRX (Recursion Pharmaceuticals) average time for price targets to be met?

On average it took 48.43 days on average for the stock forecasts to be realized with a an average price target met ratio 64.29

Which analyst has the current highest performing score on RXRX (Recursion Pharmaceuticals) with a proven track record?

GIL BLUM

Which analyst has the current lower performing score on RXRX (Recursion Pharmaceuticals) with a proven track record?

GAL MUNDA

Which analyst has the most public recommendations on RXRX (Recursion Pharmaceuticals)?

Gil Blum works at NEEDHAM and has 8 price targets and 10 ratings on RXRX

Which analyst is the currently most bullish on RXRX (Recursion Pharmaceuticals)?

Gal Munda with highest potential upside - $25.06

Which analyst is the currently most reserved on RXRX (Recursion Pharmaceuticals)?

Mani Foroohar with lowest potential downside - $0.06

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?